Pipeline Embolization Device for Intracranial Aneurysms in a Large Chinese Cohort: Complication Risk Factor Analysis

Abstract

During intracranial aneurysm embolization with the Pipeline embolization device (PED), ischemic and hemorrhagic complications have been observed in cases among Western populations. The postmarket multicenter registry study on the embolization of intracranial aneurysms with the PED in China, i.e., the PLUS study, was performed to assess real-world predictors of complications and functional outcomes in patients treated with the PED in a Chinese population. All patients with intracranial aneurysms who underwent embolization using the PED between November 2014 and October 2019 across 14 centers in China were included. The study endpoints included preoperative and early postoperative (< 30 days) functional outcomes (modified Rankin scale [mRS] scores) and complications related to PED treatment at early postoperative and follow-up time points (3-36 months). Multivariate analysis was performed to identify risk factors for complications. A total of 1171 consecutive patients (mean age, 53.9 ± 11.4; female, 69.6% [813/1171]) with 1322 aneurysms were included in the study. Hypertension, basilar artery aneurysms, and successful deployment after adjustment or unsuccessful device deployment were found to be independent predictors of ischemic stroke, while the use of the Flex PED and incomplete occlusion immediately after treatment were protective factors. An aneurysm size > 10 mm, distal anterior circulation aneurysms, and adjunctive coiling were found to be independent predictors of delayed aneurysm rupture, distal intraparenchymal hemorrhage, and neurological compression symptoms, respectively. The rate of PED-related complications in the PLUS study was similar to that in Western populations. The PLUS study identified successful deployment after adjustment or unsuccessful device deployment and the degree of immediate postoperative occlusion as novel independent predictors of PEDrelated ischemic stroke in a Chinese population. ClinicalTrial.gov Identifier: NCT03831672

Stent-alone treatment of unruptured vertebral artery fusiform aneurysms: A comparison of flow diverter and conventional stents

“…Since the development of flow diverter stents, they have been used to redirect flow in fusiform aneurysms to achieve high occlusion rates with low rates of recurrence. However, a potential complication of flow diverter use in the posterior circulation is devastating brainstem stroke from occlusion or stenosis of a critical arterial branch ( 19 , 20 ). Our study directly compared complications and clinical and angiographic outcomes between flow diverter and conventional stents in patients with VAFAs who underwent SAT.…”

Case report: Covered stent placement to treat delayed aneurysmal rupture after flow diverter-assisted coil embolization

“…In previous studies, reported incidence rates of DAR after FD placement ranged between 0.6 and 4% ( 9 ). The multicenter Chinese PLUS study reported an incidence of 2.1% ( 3 ). Approximately 80% of DARs occur within 30 days of the procedure.…”

“…Flow diverter (FD) is an essential tool in endovascular treatment of large and giant intracranial aneurysms that can achieve satisfactory clinical and angiographic outcomes ( 2 ). However, it is associated with several complications, particularly delayed aneurysm rupture (DAR), which may cause severe neurological dysfunction or death ( 3 ). The mechanism of DAR after FD placement is not known.…”

A novel score for evaluating cerebral aneurysms treated with flow diversion: 4F-flow diversion predictive score

“…This is a subgroup study of the PLUS study. 8 , 9 Three of the 14 centers were excluded because of a lack of complete angiographic imaging data. All patients with intracranial aneurysms who underwent embolization using the PED between November 2014 and October 2019 in 11 centers and who provided written informed consent for the use of any recognizable patient photographs were included.…”